Explore the Advancing Community Oncology Report to get exclusive insights from 200+ community oncologists and administrators alongside perspectives from leading oncologists and McKesson leaders. Download report: bit.ly/4pCAhNu
Today, we announced a definitive agreement to acquire Precision Medicine Group, a global provider of biomarker-driven clinical research and biopharma commercialization services. Learn more: bit.ly/4zExNE0
Cancer care is more complex than ever. At Ontada, we’re exploring the vision of the intelligent medical record, a connected approach designed to bring patient information, clinical insights and decision support closer to the point of care. Learn more: bit.ly/4gbUvdG
How do you lead through complexity while keeping people and purpose at the center? In the latest Coffee + Connection, Dave Rescober shares lessons on leadership, continuous learning and technology that supports better patient outcomes. Watch now: bit.ly/4wucWk3.
Payer confidence in cell and gene therapies is growing. But access remains a challenge. Why? Cost density, combined with fragmented reimbursement and access processes. See what it means for CGT commercialization: bit.ly/4g3AgyT